SOCRATES: SOCial Risk and diAbetes ouTcomEs Study
苏格拉底:社会风险和糖尿病结果研究
基本信息
- 批准号:10297100
- 负责人:
- 金额:$ 64.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdoptedAffectAgeAreaBlood PressureCaringCharacteristicsClinicClinicalCommunitiesComplementComplexComplications of Diabetes MellitusDataData ElementData SetData SourcesDiabetes MellitusDiastolic blood pressureDimensionsDisadvantagedEconomic ConditionsEffectivenessEthnic OriginFoodFrequenciesFutureGenderGlycosylated hemoglobin AHealthHealth PersonnelIndividualInterventionInterviewInvestigationKnowledgeLDL Cholesterol LipoproteinsLearningLinkLocationLow-Density LipoproteinsMachine LearningMethodsMicrovascular DysfunctionMissionModelingNational Institute of Diabetes and Digestive and Kidney DiseasesNeighborhood Health CenterNeighborhoodsNon-Insulin-Dependent Diabetes MellitusOutcomeOutcome StudyPathway interactionsPatientsPatternPopulationProliferatingPublic Health InformaticsQualitative EvaluationsQualitative ResearchRaceRegression AnalysisReportingResearchResourcesRiskServicesSocial WorkSocioeconomic StatusStructureSurveysSystemTarget PopulationsTestingTransportationVariantWorkbasecholesterol controlcommunity clinicdata resourcedesigndiabetes managementeffective interventionfood insecurityhealth equityhealth managementhigh riskhousing instabilityimprovedimproved outcomeinnovationknowledge basemachine learning methodmacrovascular diseasenovelpopulation healthprogramsracial and ethnicreferral servicesresponsescreeningsocial
项目摘要
ABSTRACT
Health-related social needs, particularly food insecurity, housing instability, and transportation barriers, are
associated with poor outcomes for people with type 2 diabetes mellitus (T2DM). In particular, these factors are
associated with worse glycemic, blood pressure, and LDL cholesterol control, which significantly increases the
risk of macrovascular and microvascular complications. They are also key drivers of racial/ethnic and
socioeconomic status-based disparities in diabetes outcomes. Thus, there is a growing call for interventions to
address these needs and improve T2DM outcomes. However little research has assessed whether changes in
health-related social needs are associated with changes in T2DM outcomes.
This knowledge gap hampers efforts to develop effective interventions. Addressing it will provide much-
needed evidence on which patients to screen for which social needs, and on which interventions targeting
social needs are most likely to improve T2DM outcomes. The pathways linking social needs and T2DM
outcomes are likely characterized by interactions between individual- (e.g., needs, age, gender, race/ethnicity),
clinic- (e.g., clinic characteristics; specifics of the intervention), and area-level factors (e.g., local economic
conditions; community resources). Given this complexity, a multi-pronged approach is needed. We will
combine 3 methods of investigation: 1) longitudinal, multi-level, regression analysis; 2) innovative machine
learning methods to detect novel combinations of factors associated with heterogeneous response to health-
related social needs and health-related social needs interventions while avoiding spurious findings; and 3)
thoughtful qualitative investigation. Such an analysis has never before been possible, because the needed
data elements have not been united.
This proposal seeks to answer whether improvements in specific health-related social needs are
associated with improvements in specific clinical outcomes, in what circumstances, and which approaches to
addressing health-related social needs, if any, best improve outcomes. We will leverage what we believe to be
the nation’s largest dataset of patient-reported health-related social needs, clinical outcomes, and community-
and clinic-level data. We will examine whether changes in health-related social needs are associated with
changes in hemoglobin A1c, systolic and diastolic blood pressure, and LDL cholesterol. Further, we will
evaluate whether clinic-based interventions seem to improve these outcomes, and if there are important
variations in these interventions that are associated with different response to the intervention. The proposed
work will yield important, previously unavailable evidence on how to refine and improve health-related social
need interventions. Specifically, it will help us understand better how better to care for a population at high risk
for T2DM complications. Overall, this project will substantially advance NIDDK’s mission to improve health
equity for vulnerable individuals with T2DM.
摘要
与健康有关的社会需求,特别是粮食不安全、住房不稳定和交通障碍,
与2型糖尿病(T2 DM)患者的不良结局相关。具体而言,这些因素是
与血糖、血压和低密度脂蛋白胆固醇控制较差相关,这显著增加了
大血管和微血管并发症的风险。他们也是种族/族裔和
社会经济地位在糖尿病结局中的差异。因此,越来越多的人呼吁采取干预措施,
满足这些需求并改善T2 DM结局。然而,很少有研究评估是否有变化,
健康相关的社会需求与T2 DM结局的变化相关。
这种知识差距阻碍了制定有效干预措施的努力。解决这一问题将提供很多-
需要证据来证明哪些患者需要筛查哪些社会需求,以及针对哪些干预措施
社会需求最有可能改善T2 DM的结局。联系社会需求和T2 DM的途径
结果的特征可能在于个体之间的相互作用(例如,需求、年龄、性别、种族/民族),
诊所-(例如,临床特征;干预的细节),和区域水平因素(例如,地方经济
社区资源(Community Resources)鉴于这种复杂性,需要采取多管齐下的办法。我们将
联合收割机3种调查方法:1)纵向、多层次、回归分析; 2)创新机
学习方法,以检测与对健康的异质反应相关的因素的新组合,
相关的社会需求和健康相关的社会需求干预措施,同时避免虚假的发现;以及3)
深入的定性研究。这样的分析以前从来没有可能,因为需要
数据元素尚未统一。
这项建议旨在回答改善与健康有关的具体社会需求是否
与特定临床结局的改善相关,在什么情况下,以及
解决与健康有关的社会需求,如果有的话,最能改善结果。我们将利用我们认为是
全国最大的患者报告的健康相关社会需求,临床结果和社区数据集-
临床数据。我们将研究与健康相关的社会需求的变化是否与
血红蛋白A1 c、收缩压和舒张压以及LDL胆固醇的变化。此外,我们将
评估基于临床的干预是否似乎可以改善这些结果,以及是否有重要的
这些干预措施的变化与对干预措施的不同反应有关。拟议
这项工作将产生重要的,以前无法获得的证据,说明如何完善和改善与健康有关的社会
需要干预。具体来说,它将帮助我们更好地了解如何更好地照顾高危人群
2型糖尿病并发症总的来说,该项目将大大推进NIDDK改善健康的使命
为T2 DM患者提供平等的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seth A Berkowitz其他文献
Medically Tailored Meals to Address the Health Consequences of Food Insecurity.
医学定制餐食可解决粮食不安全对健康造成的影响。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:158.5
- 作者:
Seth A Berkowitz;Jean Terranova - 通讯作者:
Jean Terranova
Financial Hardship Among Traditional Medicare and Medicare Advantage Enrollees With and Without Food Insecurity.
有或没有粮食不安全的传统医疗保险和医疗保险优势参保者的经济困难。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:5.7
- 作者:
Sungchul Park;Seth A Berkowitz - 通讯作者:
Seth A Berkowitz
Seth A Berkowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seth A Berkowitz', 18)}}的其他基金
SOCRATES: SOCial Risk and diAbetes ouTcomEs Study
苏格拉底:社会风险和糖尿病结果研究
- 批准号:
10666513 - 财政年份:2021
- 资助金额:
$ 64.17万 - 项目类别:
SOCRATES: SOCial Risk and diAbetes ouTcomEs Study
苏格拉底:社会风险和糖尿病结果研究
- 批准号:
10477298 - 财政年份:2021
- 资助金额:
$ 64.17万 - 项目类别:
Food as Medicine for HIV: A Randomized Trial of Medically Tailored Meals and Lifestyle Intervention
食物作为治疗艾滋病毒的药物:医学定制膳食和生活方式干预的随机试验
- 批准号:
10311121 - 财政年份:2020
- 资助金额:
$ 64.17万 - 项目类别:
Food as Medicine for HIV: A Randomized Trial of Medically Tailored Meals and Lifestyle Intervention
食物作为治疗艾滋病毒的药物:医学定制膳食和生活方式干预的随机试验
- 批准号:
10524741 - 财政年份:2020
- 资助金额:
$ 64.17万 - 项目类别:
Food is Medicine: A Randomized Clinical Trial of Medically Tailored Meals For Individuals with Type 2 Diabetes Mellitus and Food Insecurity
食物就是药物:针对 2 型糖尿病和食物不安全患者的医学定制膳食的随机临床试验
- 批准号:
10682586 - 财政年份:2020
- 资助金额:
$ 64.17万 - 项目类别:
Food is Medicine: A Randomized Clinical Trial of Medically Tailored Meals For Individuals with Type 2 Diabetes Mellitus and Food Insecurity
食物就是药物:针对 2 型糖尿病和食物不安全患者的医学定制膳食的随机临床试验
- 批准号:
10032868 - 财政年份:2020
- 资助金额:
$ 64.17万 - 项目类别:
Food is Medicine: A Randomized Clinical Trial of Medically Tailored Meals For Individuals with Type 2 Diabetes Mellitus and Food Insecurity
食物就是药物:针对 2 型糖尿病和食物不安全患者的医学定制膳食的随机临床试验
- 批准号:
10460166 - 财政年份:2020
- 资助金额:
$ 64.17万 - 项目类别:
Food is Medicine: A Randomized Clinical Trial of Medically Tailored Meals For Individuals with Type 2 Diabetes Mellitus and Food Insecurity
食物就是药物:针对 2 型糖尿病和食物不安全患者的医学定制膳食的随机临床试验
- 批准号:
10226242 - 财政年份:2020
- 资助金额:
$ 64.17万 - 项目类别:
Understanding & Overcoming Food Insecurity in Diabetes Patients
理解
- 批准号:
9611162 - 财政年份:2016
- 资助金额:
$ 64.17万 - 项目类别:
Understanding & Overcoming Food Insecurity in Diabetes Patients
理解
- 批准号:
9087461 - 财政年份:2016
- 资助金额:
$ 64.17万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 64.17万 - 项目类别:
Research Grant